Table 3—

Patients with and without worsening of asthmatic symptoms

WithWithout
Patients n2320
SN/ST17/66/14
FEV1 %84 (80–88)83 (79–87)
eNO ppb19.1 (13.1–25.2)*11.6 (7.6–15.7)
Adenosine nM15.5 (12.4–18.5)**9.5 (7.1–11.8)
  • Data are presented as mean (95% confidence interval)

  • SN: steroid-naive asthmatic patients

  • ST: steroid-treated asthmatic patients

  • FEV1: forced expiratory volume in one second

  • eNO: exhaled nitric oxide

  • ppb: parts per billion

  • *: p<0.05 between groups

  • **: p<0.01 between groups